Start Here — The Short Version
PIH is not a stain. It is an active melanocyte response — inflammation releases prostaglandins and cytokines that switch melanocytes into overproduction, and that continues after the original spot has healed.
Which is why it takes months rather than days, and why sun protection outranks every active ingredient — UV re-triggers the same pathway daily.
One correction to the standard advice: on deeper skin, tinted sunscreen beats clear. Visible light drives pigmentation in Fitzpatrick IV–VI and is not blocked by transparent filters — iron oxides are what block it.
This article is for educational purposes only and does not constitute medical advice. Persistent, severe or worsening hyperpigmentation should be assessed by a qualified dermatologist. Individual results vary.
PIH is the most common pigmentation concern in South Asian, African and Middle Eastern skin, and the most misunderstood. Calling it a stain sets the expectation that it should clear quickly — and when it does not, people escalate to stronger products, which is precisely how it gets worse.
In This Article
The Mechanism
Why It Isn't A Stain
When skin is inflamed — by acne, eczema, an irritating product or physical trauma — keratinocytes release arachidonic acid metabolites, which become prostaglandins, leukotrienes and cytokines. These signal melanocytes to increase tyrosinase activity and produce melanin well beyond normal levels.
That excess melanin is packaged into melanosomes, handed to surrounding keratinocytes, and carried upward as those cells migrate over roughly 28 to 40 days. The mark you see is melanin travelling toward the surface.
The distinction that matters
A stain is passive — deposited once, then fading. PIH is active. Melanocytes remain in an elevated state after the inflammation resolves, continuing to produce excess melanin for weeks.
And UV restarts the same pathway every day it reaches unprotected skin. Which means without sun protection, brightening actives are reducing melanin production while UV increases it — and the two can cancel out.
Where inflammation is severe, melanin can breach the dermo-epidermal junction and be taken up by macrophages in the dermis. That is dermal PIH — and it is a different problem, covered below.
First Question
First: Is It PIH Or PIE?
Before choosing any active, establish which of two entirely different things you are looking at — because brightening ingredients do nothing for one of them.
| PIH | PIE | |
|---|---|---|
| What it is | Excess melanin | Dilated or damaged capillaries |
| Colour | Brown, tan or grey-blue | Pink, red — or dusky violaceous on deeper skin |
| Press test | Colour stays | Blanches — pales briefly under pressure |
| What helps | Tyrosinase inhibitors, turnover, SPF | Not brightening actives — vascular concern; time and gentleness, or a dermatologist |
The press test settles it in seconds — press the mark with a clean fingertip and release. If it pales momentarily, it is vascular. If the colour is unchanged, it is pigment.
This matters especially on Fitzpatrick III–VI, where PIE frequently appears dusky or violaceous rather than obviously red, and gets misread as PIH. Months of brightening actives on a vascular mark produce nothing except the irritation risk of using them.
Depth
Epidermal Vs Dermal
| Epidermal | Dermal | |
|---|---|---|
| Appearance | Brown, tan, dark brown | Grey, blue-grey, ashen |
| Where the melanin sits | Upper epidermis | Dermis, inside macrophages |
| Topical response | Responds to actives and SPF | Largely out of reach of topicals |
| Typical course | Months with consistent care | Prolonged; dermatologist assessment warranted |
Most post-acne marks on Indian skin are epidermal or mixed, which is genuinely good news — they are the responsive kind. Grey or ashen marks following cystic lesions, deep trauma or aggressive peels suggest dermal involvement and are worth having assessed rather than treated with more actives.
Skin Tone
Why It's Worse On Deeper Skin
Not more melanocytes — more reactive ones. Fitzpatrick III–VI skin contains a similar melanocyte density to lighter skin. What differs is that those cells are larger and more dendritic, and produce bigger melanosomes carrying more melanin. The same inflammatory signal yields a proportionally larger pigment response.
Higher melanin density per keratinocyte also means more turnover cycles are needed to clear it, even once production has stopped. Both facts point in the same direction: prevention of inflammation matters more here than treatment of the resulting mark.
The consequence for product choice
The correct response to a bigger pigment response is not stronger actives. Irritation is itself an inflammatory trigger, so an aggressive routine generates fresh PIH while working on the old — which is the most common reason people report their marks getting worse despite treating them diligently. Gentle and consistent beats strong and reactive, and that is a mechanistic conclusion rather than a cautious one.
The Foundation
Sun Protection — And The Tint Correction
UV directly upregulates tyrosinase. On melanocytes already in a post-inflammatory elevated state, that adds to a raised baseline — deepening marks and extending how long they take to clear. Without sun protection, brightening actives reduce melanin production while UV increases it, and the net effect can approach zero.
Why tinted beats clear here
The common advice for deeper skin is to choose a clear chemical sunscreen to avoid white cast. For pigmentation specifically, that is the wrong way round.
Visible light induces pigmentation in Fitzpatrick IV–VI skin — darker and longer-lasting than that from comparable UVA exposure. And SPF measures UVB, PA measures UVA; neither measures visible light, which passes straight through transparent filters.
Iron oxides — the pigments that make a sunscreen tinted — block it. A randomised trial by Boukari and colleagues found tinted sunscreen reduced pigmentary relapse compared with non-tinted using the same UV filters.
The compliance point still stands, and is now easier to satisfy: a sunscreen you will actually wear daily beats a better one you avoid. But modern tinted formulas come in shade ranges, so the answer is a tinted sunscreen matched to your tone rather than a clear one. Look for iron oxides on the ingredient list — usually CI 77491, CI 77492 and CI 77499.
Broad-spectrum, SPF 30 or above, every day including overcast ones. Reapply during extended outdoor exposure.
Actives
Ingredients, By Pathway Step
Grouping by where each acts is more useful than listing them, because it shows which combinations genuinely add something and which duplicate each other.
| Ingredient | Where it acts |
|---|---|
| Tranexamic acid | Upstream — inhibits plasmin, reducing the signalling that activates melanocytes |
| Undecylenoyl phenylalanine | Upstream — modulates α-MSH receptor signalling |
| Alpha-arbutin | Synthesis — competitive tyrosinase inhibition |
| Vitamin C | Synthesis — reduces dopaquinone; also antioxidant |
| Niacinamide | Transfer — blocks melanosome handoff to keratinocytes |
| Azelaic acid | Synthesis + inflammation — useful where acne is ongoing |
| Retinoids | Multiple points + turnover — strong evidence, but irritation must be managed carefully |
| AHAs | Clearance — speeds shedding of pigment-carrying cells. Use gently; irritation creates fresh PIH |
Combining across steps is what compounds. Two tyrosinase inhibitors together largely duplicate each other; an upstream blocker plus a tyrosinase inhibitor plus a transfer blocker do not. That is the reasoning behind multi-active formulas — make less, move less, and stop the signal that started it.
Avoid
What Makes It Worse
- Squeezing spots. Pressure ruptures the follicle wall below the surface, spilling contents into surrounding tissue and extending inflammation deeper — which is how epidermal PIH becomes dermal. The most damaging single habit.
- Escalating to stronger actives. High-percentage acids or retinoids on unacclimatised skin cause irritation, and irritation generates fresh PIH. Actives intended to clear marks create new ones.
- Physical scrubs. Microtrauma on skin already producing excess melanin.
- Skipping sun protection. Undoes the actives daily, and on deeper skin the visible-light component is not covered by clear formulas.
- Lemon juice. Worth naming specifically — it contains furanocoumarins that are phototoxic, and applied before sun exposure can cause a burn-like reaction leaving pigmentation far worse than the original mark.
Realistic timeline
Fading follows keratinocyte turnover — roughly 28 to 40 days per cycle, slower with age, and several cycles are needed. Expect measurable change around 8 weeks and meaningful change around 16 to 24, with consistent actives and daily sun protection. Changing products every few weeks guarantees never finding out what works.
FAQ
Frequently Asked Questions
The Bottom Line
PIH is an active response, not a stain — which is why it takes months and why sun protection outranks every active. Check first whether it is PIH or PIE with the press test. On deeper skin, choose tinted rather than clear sunscreen, since iron oxides block the visible light that SPF and PA do not measure. And resist escalating — irritation creates the very marks you are treating.
Scientific References
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. Journal of Clinical and Aesthetic Dermatology. 2010;3(7):20–31.
- Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. American Journal of Clinical Dermatology. 2018;19(4):489–503.
- Silpa-archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview. Journal of the American Academy of Dermatology. 2017;77(4):591–605.
- Nouveau-Richard S, Yang Z, Mac-Mary S, et al. Skin ageing: a comparison between Chinese and European populations — and related studies characterising pigmentation in Asian skin. Skin Pharmacology and Physiology.
- Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. Journal of Investigative Dermatology. 2010;130(8):2092–2097.
- Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light. Journal of the American Academy of Dermatology. 2015;72(1):189–190.e1.
- Boo YC. Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties. Antioxidants. 2021;10(7):1129.
- Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology. 2002;147(1):20–31.
Note to editor: the original reference list was accurate and on-topic — the first in this batch for which that was true. Entries retained, with the Nouveau citation flagged for verification of exact title and volume, and Mahmoud, Boukari and Hakozaki added to support the visible-light and mechanism sections.
© 2026 Boldpurity · For educational purposes only · Not to be reproduced without permission.
